RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 45-55
  • Ebola vaccine from GSK fast-tracked into clinical trials

    LONDON/NEW YORK (Reuters) - An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into human studies and the company plans to build a stockpile of up to 10,000 doses for emergency deployment, if results are good. The research work...
  • GSK Ebola vaccine fast-tracked into U.S., UK and African trials

    LONDON (Reuters) - An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into human studies and the company plans to build up a stockpile of up to 10,000 doses for emergency deployment, if results are good. Britain's biggest...
  • China's top judge says foreigners to be allowed into Chinese courts

    BEIJING (Reuters) - China's top judge has said that foreigners will be regularly allowed into courts to listen to cases, state media reported on Thursday, as the government embarks on legal reform at a time of public discontent over many perceived...
  • New medicine offers another defense in the asthma war

    With the summer weather so unbelievably pleasant in the Lehigh Valley in recent weeks, it's been easy to forget how difficult it is for some folks to breathe around here. The good news for them is that they just got new help in their war against asthma....
  • Canada's Immunovaccine Inc says test of Ebola vaccine promising

    WINNIPEG Manitoba (Reuters) - Four monkeys survived the Ebola virus after being injected with a vaccine that included Immunovaccine Inc's technology, the tiny Canadian company said on Monday, and the announcement sent its stock soaring. The Halifax, Nova...
  • Sierra Leone 'hero' doctor's death exposes slow Ebola response

    FREETOWN/DAKAR (Reuters) - When two American aid workers recovered from Ebola after being treated with an experimental drug, the grieving family of Sierra Leone's most famous doctor wondered why he had been denied the same treatment before he died from...
  • A FONDO-Medicina extrema: la búsqueda de nuevos antibióticos

    NORWICH Inglaterra (Reuters) - Consentir a las hormigas con pétalos de rosas y naranjas frescas podría parecer una insólita manera de salvar la medicina moderna, pero los científicos de un laboratorio en el este de Inglaterra piensan que vale la pena...
  • American Ebola patients treated with ZMapp experimental drug

    American Ebola patients treated with ZMapp experimental drug
    An American doctor who contracted Ebola treating victims of the deadly virus in Liberia has recovered and has been discharged Thursday by the Atlanta hospital that treated him with an experimental drug. Dr. Kent Brantly of Texas was given ZMapp, a drug...
  • Pfizer back for AstraZeneca? Year-end move seen most likely

    LONDON (Reuters) - Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion (71 billion pounds) takeover attempt in May. But while...
  • Experimental Ebola drugs needed for 'up to 30,000 people'

    LONDON (Reuters) - Up to 30,000 people could have used experimental treatments or vaccines so far in the world's worst outbreak of Ebola currently plaguing West Africa, British scientists said on Wednesday. The calculation highlights the dilemma facing...
  • Amicus's lead drug nears approval as late-stage trial succeeds

    (Reuters) - Amicus Therapeutics Inc moved a step closer to bringing its first drug to the market after trial results paved the way for its lead drug to become the first oral treatment for patients with a disorder that causes an abnormal build-up of fat....